Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study

JOSEPH SGOUROS, GERASIMOS ARAVANTINOS, GEORGIA-ANGELIKI KOLIOU, GEORGE PENTHEROUDAKIS, FLORA ZAGOURI, AMANDA PSYRRI, DIMITRA IOANNA LAMPROPOULOU, STAMATINA DEMIRI, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GEORGE FOUNTZILAS and EPAMINONTAS SAMANTAS
Anticancer Research February 2020, 40 (2) 929-938; DOI: https://doi.org/10.21873/anticanres.14026
JOSEPH SGOUROS
1Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: josephsgouros@yahoo.co.uk
GERASIMOS ARAVANTINOS
2Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGIA-ANGELIKI KOLIOU
3Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGE PENTHEROUDAKIS
4Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Greece
5Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FLORA ZAGOURI
6Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AMANDA PSYRRI
7Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIMITRA IOANNA LAMPROPOULOU
2Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STAMATINA DEMIRI
8Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIMITRIOS PECTASIDES
9Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EVANGELIA RAZIS
10Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGE FOUNTZILAS
11Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece
12Aristotle University of Thessaloniki, Thessaloniki, Greece
13German Oncology Center, Limassol, Cyprus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EPAMINONTAS SAMANTAS
1Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 40 (2)
Anticancer Research
Vol. 40, Issue 2
February 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
JOSEPH SGOUROS, GERASIMOS ARAVANTINOS, GEORGIA-ANGELIKI KOLIOU, GEORGE PENTHEROUDAKIS, FLORA ZAGOURI, AMANDA PSYRRI, DIMITRA IOANNA LAMPROPOULOU, STAMATINA DEMIRI, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GEORGE FOUNTZILAS, EPAMINONTAS SAMANTAS
Anticancer Research Feb 2020, 40 (2) 929-938; DOI: 10.21873/anticanres.14026

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
JOSEPH SGOUROS, GERASIMOS ARAVANTINOS, GEORGIA-ANGELIKI KOLIOU, GEORGE PENTHEROUDAKIS, FLORA ZAGOURI, AMANDA PSYRRI, DIMITRA IOANNA LAMPROPOULOU, STAMATINA DEMIRI, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GEORGE FOUNTZILAS, EPAMINONTAS SAMANTAS
Anticancer Research Feb 2020, 40 (2) 929-938; DOI: 10.21873/anticanres.14026
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
  • Liberal Application of Portal Vein Embolization for Right Hepatectomy Against Hepatocellular Carcinoma: Strategy to Achieve Zero Mortality for a Damaged Liver
  • Pancreaticoenterostomy With Seromuscular-parenchymal Anastomosis for Prevention of Postoperative Pancreatic Fistula in Distal Pancreatectomy
Show more Clinical Studies

Similar Articles

Keywords

  • Biliary tract carcinoma
  • gemcitabine
  • pazopanib
  • phase II study
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire